We use cookies for a better user experience. Read our Privacy Policy

I Agree

Pigmentation Disorders Treatment Market

Pigmentation Disorders Treatment Market (Treatment - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion; Key Disease Indications - Hyperpigmentation (Melasma, Post-inflammatory Hyperpigmentation, Solar Lentigines), Hypopigmentation (Vitiligo, Albinism); End use - Hospitals, Aesthetic Clinics and Dermatology Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Pigmentation Disorders Treatment Market - Snapshot

Pigmentation is coloring. When the color of one’s skin is affected, it is called skin pigmentation disorder. Presence of melanin in skin gives the skin its color. Melanin is made by the special cells in the skin. When these cells become unhealthy or are damaged, it leaves impact on the production of melanin. Some of the pigmentation disorders attack the skin in some patches, whilst others leave undesirable impact on the entire body. Increased occurrences of skin disorders is likely to amplify growth opportunities for the global pigmentation disorders treatment market in the years to come.

An upgradation in the lifestyle of people together with augmented demand for skin lightening is likely to play an important role in propelling growth of the global pigmentation disorders treatment market in the years to come. In addition to that, availability of high disposable income and rise in the aging population is estimated to shoot up the demand for pigmentation disorders treatment.

Topical Treatment Procedures to Emerge as one of the Prominent Treatments

Some of the common types of pigmentation disorders comprise the below-mentioned

  • Albinism
  • Melasma
  • Vitiligo
  • Post-Inflammatory Hyperpigmentation (PIH) 

At present, topical treatment is dominating the global pigmentation disorders treatment market, thanks to the much better clinical outcomes in those patients who are affected with various kinds of pigmentation disorders. L-ascorbic acid, hydroquinone, and azelaic acid are some of the popular topical drugs available widely in the market.

There has been a growing prominence of chemical peels for the purpose of treatment of facial hyper-pigmentation disorders. In this procedure, chemical peels are dipped in chemicals and then are applied on face or on the targeted areas, hands, and neck to remove the dead skin cells. The removal of dead skin the triggers growth of new skin cells on the affected areas.

 Global Pigmentation Disorders Treatment Market - Snapshot

Pigmentation disorders include a large number of heterogeneous conditions that are usually characterized by altered melanocyte density, melanin concentration, or both, and result in altered pigmentation of the skin. Pigmentation disorders are of three types: hypopigmentation, depigmentation, or hyperpigmentation. Areas where pigmentation appears may be focal or diffuse. In hypopigmentation, pigments are decreased, whereas in depigmentation, pigments are completely lost, leaving the skin white. The most common disorders are melasma (hyperpigmentary) and vitiligo (hypopigmentary). The global pigmentation disorders treatment market was valued at around US$ 5,225 Mn in 2017 and is anticipated to expand at a CAGR of more than 6.8% from 2018 to 2026 to reach around US$ 9,268.6 Mn in 2026. Several factors such as augmented adoption of lasers in pigmentation disorders treatment, decrease in social taboos boosting acceptance of pigmentation disorders treatment measures, and increase in prevalence of pigmentation-related disorders are driving the global pigmentation disorders treatment market.

pigmentation disorders treatment market

After stringent restructuring of regulations against dermo-cosmetic products and services, companies have started focussing on efficacy and quality with high investments in R&D. This has ultimately helped boost technological development and emergence of new products, services, and devices in the pigmentation disorder treatment market. The products and services have been moderated by regulatory bodies and have minimal side effects.

Opportunities for introducing new products, services, and devices are high as the market consists of established players and their brands. However, the market is still in search of highly efficient products and portable and technologically advanced devices. Safety and efficacy are major concerns in the pigmentation disorders treatment market. Therefore, introduction of such products presents a window of opportunity for new players to enter the market and establish themselves. The appreciation of regulatory compliance is a major factor that contributes to the success or failure of treatments, thus affecting sales. Galderma launched the triple combination to improve compliance of its key product, Tri-luma. Increased patient and provider awareness is also likely to help increase patient share of many marketed therapies during the forecast period.

The pigmentation disorder treatment market has been segmented based on treatment, disease indication, end-user, and region. In terms of treatment, the topical drugs segment is estimated to account for a prominent share of the market. An increasing number of patients with pigmentation disorders are visiting dermatologists, and topical drugs are being prescribed to these patients. With an existing unmet need for better treatment armamentarium for severe, recalcitrant patients and an estimated drug-treated population that is expected to double over the next decade, topical drugs is an attractive segment for drug developers. This is expected to fuel commercial interest in the development of tropical drugs.

Based on disease indication, the vitiligo and melasma segment constituted a major share of the market in 2017. The segment is likely to expand at a significant growth rate as compared to other disease indication segments during the forecast period. Globally, the prevalence of vitiligo and melasma varies. Women are far more likely to be affected by melisma than men, and both sexes are affected equally by vitiligo. In pigmentation, inadequate patient compliance still remains a significant unmet need. This single factor has hindered the ability of patients to achieve maximum treatment benefit, given the therapeutic options currently available, and has resulted in multiple failed treatment attempts.

In terms of region, the global pigmentation disorder treatment market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The pigmentation disorders treatment market is dominated by Asia Pacific. The market in the region is likely gain market share and expand at a rapid pace during the forecast period. The market in Asia Pacific is likely to be boosted by an increase in population, awareness about pigmentation disorder treatments and products, and growing economies. Furthermore, the pigmentation disorder treatment market in emerging economies of the Middle East, Latin America, and Africa is anticipated to add to the growth of the global market.

Prominent players in the global pigmentation disorder treatment market include Bayer AG, ALLERGAN, Galderma S.A., SkinCeuticals, Pierre Fabre, EpiPharm AG, RXi Pharmaceuticals Corporation, Obagi Cosmeceuticals LLC, and Vivier Pharma. The prevalent trend in the market is the strategic acquisition of key dermatology products by Big Pharma. A notable event in 2009 involved the acquisition of Stiefel, a leading dermatology company, by GSK for US$ 3.6 Bn.

The global pigmentation disorders treatment market has been segmented as follows:

Treatment

  • Topical Drugs
  • Laser Therapy
  • Chemical Peels
  • Microdermabrasion
  • Phototherapy
  • Others

Disease Indication

  • Hypopigmentation
    • Vitiligo
    • Albinism
    • Others
  • Hyperpigmentation
    • Melasma
    • Post-inflammatory Hyperpigmentation
    • Solar Lentigines
    • Others

End-user

  • Hospitals
  • Aesthetic Clinics & Dermatology Centers
  • Others

Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia & New Zealand
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Rest of Middle East & Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Section 01 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights

Section 02 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology

Section 03 Executive Summary
3.1 Global Pigmentation Disorders Treatment Market Size (US$ Mn)
3.2 Global Pigmentation Disorders Treatment Market Snapshot, 2017
3.3 Global Pigmentation Disorders Treatment Market: Opportunity Map

Section 04 Market Overview
4.1 Overview
4.2 Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, 2016–2026
4.3 Global Pigmentation Disorders Treatment Market Outlook
4.4 Global Pigmentation Disorders Treatment Market: Porter’s Five Forces Analysis
4.5 Pigmentation Disorders Treatment Market: Pipeline Analysis
4.6 Key Partnership & Acquisitions
4.7 Policies and Regulations, by Region
4.8 Disease Prevalence and Incidence Rate Globally

Section 05 Market Dynamics
5.1 Drivers
5.2 Restraints
5.3 Opportunity Analysis
5.4 Opportunities
5.5 Trends

Section 06 Pigmentation Disorders Treatment Market Analysis, by Treatment
6.1 Introduction
6.2 Global Pigmentation Disorders Treatment Market Value Share Analysis, by Treatment
6.3 Pigmentation Disorders Treatment Market Analysis, by Treatment
    6.3.1 Topical Drugs
    6.3.2 Laser Therapy
    6.3.3 Chemical Peels
    6.3.4 Microdermabrasion
    6.3.5 Phototherapy
    6.3.6 Others
6.4 Pigmentation Disorders Treatment Market Attractiveness Analysis, by Treatment

Section 07 Pigmentation Disorders Treatment Market Analysis, by Disease Indication
7.1 Introduction
7.2 Global Pigmentation Disorders Treatment Market Value Share Analysis, by Disease Indication
7.3 Pigmentation Disorders Treatment Market Analysis, by Disease Indication
    7.3.1 Global Pigmentation Disorders Treatment Market Analysis, by Hypopigmentation
           7.3.1.1 Vitiligo
           7.3.1.2 Albinism
           7.3.1.3 Others
    7.3.2 Global Pigmentation Disorders Treatment Market Analysis, by Hyperpigmentation
           7.3.2.1 Melasma
           7.3.2.2 Post-inflammatory Pigmentation
           7.3.2.3 Solar Lentigines
           7.3.2.4 Others
7.4 Pigmentation Disorders Treatment Market Attractiveness Analysis, by Disease Indication
7.5 Pigmentation Disorders Treatment Market Attractiveness Analysis, by Hypopigmentation
7.6 Pigmentation Disorders Treatment Market Attractiveness Analysis, by Hyperpigmentation

Section 08 Pigmentation Disorders Treatment Market Analysis, by End-user
8.1 Introduction
8.2 Global Pigmentation Disorders Treatment Market Value Share Analysis, by End-user
8.3 Pigmentation Disorders Treatment Market Analysis, by End-user
    8.3.1 Hospitals
    8.3.2 Aesthetic Clinics & Dermatology Centers
    8.3.3 Others
8.4 Pigmentation Disorders Treatment Market Attractiveness Analysis, by End-user

Section 09 Pigmentation Disorders Treatment Market Analysis, by Region
9.1 Global Pigmentation Disorders Treatment Market Snapshot, by Country
9.2 Global Pigmentation Disorders Treatment Market Value Share Analysis, by Region
9.3 Pigmentation Disorders Treatment Market Forecast, by Region
    9.3.1 North America
    9.3.2 Europe
    9.3.3 Asia Pacific
    9.3.4 Latin America
    9.3.5 Middle East & Africa
9.4 Pigmentation Disorders Treatment Market Attractiveness Analysis, by Region

Section 10 North America Pigmentation Disorders Treatment Market Analysis
10.1 Key Findings
10.2 North America Pigmentation Disorders Treatment Market Overview
10.3 North America Market Value Share Analysis, by Treatment
10.4 North America Market Forecast, by Treatment
    10.4.1 Topical Drugs
    10.4.2 Laser Therapy
    10.4.3 Chemical Peels
    10.4.4 Microdermabrasion
    10.4.5 Phototherapy
    10.4.6 Others
10.5 North America Market Value Share Analysis, by Disease Indication
10.6 North America Market Forecast, by Disease Indication
    10.6.1 North America Market Forecast, by Hypopigmentation
           10.6.1.1 Vitiligo
           10.6.1.2 Albinism
           10.6.1.3 Others
    10.6.2 North America Market Forecast, by Hyperpigmentation
           10.6.2.1 Melasma
           10.6.2.2 Post-inflammatory Pigmentation
           10.6.2.3 Solar Lentigines
           10.6.2.4 Others
10.7 North America Market Value Share Analysis, by End-user
10.8 North America Market Forecast, by End-user
    10.8.1 Hospitals
    10.8.2 Aesthetic Clinics & Dermatology Centers
    10.8.3 Others
10.9 Market Analysis, by Country
10.10 Market Value Share Analysis, by Country
10.11 Market Size (US$ Mn) Forecast, by Country, 2018–2026
    10.11.1 U.S.
    10.11.2 Canada
10.12 Market Attractiveness Analysis
    10.12.1 By Treatment
    10.12.2 By Disease Indication
    10.12.3 By Disease Hypopigmentation
    10.12.4 By Disease Hyperpigmentation
    10.12.5 By End-user
    10.12.6 By Country

Section 11 Europe Pigmentation Disorders Treatment Market Analysis
11.1 Key Findings
11.2 Europe Pigmentation Disorders Treatment Market Overview
11.3 Europe Market Value Share Analysis, by Treatment
11.4 Europe Market Forecast, by Treatment
    11.4.1 Topical Drugs
    11.4.2 Laser Therapy
    11.4.3 Chemical Peels
    11.4.4 Microdermabrasion
    11.4.5 Phototherapy
    11.4.6 Others
11.5 Europe Market Value Share Analysis, by Disease Indication
11.6 Europe Market Forecast, by Disease Indication
    11.6.1 Europe Market Forecast, by Hypopigmentation
           11.6.1.1 Vitiligo
           11.6.1.2 Albinism
           11.6.1.3 Others
    11.6.2 Europe Market Forecast, by Hyperpigmentation
           11.6.2.1 Melasma
           11.6.2.2 Post-inflammatory Pigmentation
           11.6.2.3 Solar Lentigines
           11.6.2.4 Others
11.7 Europe Market Value Share Analysis, by End-user
11.8 Europe Market Forecast, by End-user
    11.8.1 Hospitals
    11.8.2 Aesthetic Clinics & Dermatology Centers
    11.8.3 Others
11.9 Market Analysis, by Country
11.10 Market Value Share Analysis, by Country
11.11 Market Size (US$ Mn) Forecast, by Country, 2018–2026
    11.11.1 Germany
    11.11.2 France
    11.11.3 U.K.
    11.11.4 Italy
    11.11.5 Spain
    11.11.6 Rest of Europe
11.12 Market Attractiveness Analysis
    11.12.1 By Treatment Type
    11.12.2 By Disease Indication
    11.12.3 By Disease Hypopigmentation
    11.12.4 By Disease Hyperpigmentation
    11.12.5 By End-user
    11.12.6 By Country

Section 12 Asia Pacific Pigmentation Disorders Treatment Market Analysis
12.1 Key Findings
12.2 Asia Pacific Pigmentation Disorders Treatment Market Overview
12.3 Asia Pacific Market Value Share Analysis, by Treatment
12.4 Asia Pacific Market Forecast, by Treatment
    12.4.1 Topical Drugs
    12.4.2 Laser Therapy
    12.4.3 Chemical Peels
    12.4.4 Microdermabrasion
    12.4.5 Phototherapy
    12.4.6 Others
12.5 Asia Pacific Market Value Share Analysis, by Disease Indication
12.6 Asia Pacific Market Forecast, by Disease Indication
    12.6.1 Asia Pacific Market Forecast, by Hypopigmentation
           12.6.1.1 Vitiligo
           12.6.1.2 Albinism
           12.6.1.3 Others
    12.6.2 Asia Pacific Market Forecast, by Hyperpigmentation
           12.6.2.1 Melasma
           12.6.2.2 Post-inflammatory Pigmentation
           12.6.2.3 Solar Lentigines
           12.6.2.4 Others
12.7 Asia Pacific Market Value Share Analysis, by End-user
12.8 Asia Pacific Market Forecast, by End-user
    12.8.1 Hospitals
    12.8.2 Aesthetic Clinics & Dermatology Centers
    12.8.3 Others
12.9 Market Analysis, by Country
12.10 Market Value Share Analysis, by Country
12.11 Market Size (US$ Mn) Forecast, by Country, 2018–2026
    12.11.1 China
    12.11.2 Japan
    12.11.3 India
    12.11.4 Australia & New Zealand
    12.11.5 Rest of Asia Pacific
12.12 Market Attractiveness Analysis
    12.12.1 By Treatment
    12.12.2 By Disease Indication
    12.12.3 By Disease Hypopigmentation
    12.12.4 By Disease Hyperpigmentation
    12.12.5 By End-user
    12.12.6 By Country

Section 13 Latin America Pigmentation Disorders Treatment Market Analysis
13.1 Key Findings
13.2 Latin America Pigmentation Disorders Treatment Market Overview
13.3 Latin America Market Value Share Analysis, by Treatment
13.4 Latin America Market Forecast, by Treatment
    13.4.1 Topical Drugs
    13.4.2 Laser Therapy
    13.4.3 Chemical Peels
    13.4.4 Microdermabrasion
    13.4.5 Phototherapy
    13.4.6 Others
13.5 Latin America Market Value Share Analysis, by Disease Indication
13.6 Latin America Market Forecast, by Disease Indication
    13.6.1 Latin America Market Forecast, by Hypopigmentation
           13.6.1.1 Vitiligo
           13.6.1.2 Albinism
           13.6.1.3 Others
    13.6.1 Latin America Market Forecast, by Hyperpigmentation
           13.6.2.1 Melasma
           13.6.2.2 Post-inflammatory Pigmentation
           13.6.2.3 Solar Lentigines
           13.6.2.4 Others
13.7 Latin America Market Value Share Analysis, by End-user
13.8 Latin America Market Forecast, by End-user
    13.8.1 Hospitals
    13.8.2 Aesthetic Clinics & Dermatology Centers
    13.8.3 Others
13.9 Market Analysis, by Country
13.10 Market Value Share Analysis, by Country
13.11 Market Size (US$ Mn) Forecast, by Country, 2018–2026
    13.11.1 Brazil
    13.11.2 Mexico
    13.11.3 Rest of Latin America
13.12 Market Attractiveness Analysis
    13.12.1 By Treatment
    13.12.2 By Disease Indication
    13.12.3 By Disease Hypopigmentation
    13.12.4 By Disease Hyperpigmentation
    13.12.5 By End-user
    13.12.6 By Country

Section 14 Middle East & Africa Pigmentation Disorders Treatment Market Analysis
14.1 Key Findings
14.2 Middle East & Africa Pigmentation Disorders Treatment Market Overview
14.3 Middle East & Africa Market Value Share Analysis, by Treatment
14.4 Middle East & Africa Market Forecast, by Treatment
    14.4.1 Topical Drugs
    14.4.2 Laser Therapy
    14.4.3 Chemical Peels
    14.4.4 Microdermabrasion
    14.4.5 Phototherapy
    14.4.6 Others
14.5 Middle East & Africa Market Value Share Analysis, by Disease Indication
14.6 Middle East & Africa Market Forecast, by Disease Indication
    14.6.1 Middle East & Africa Market Forecast, by Hypopigmentation
           14.6.1.1 Vitiligo
           14.6.1.2 Albinism
           14.6.1.3 Others
    14.6.2 Middle East & Africa Market Forecast, by Hyperpigmentation
           14.6.2.1 Melasma
           14.6.2.2 Post-inflammatory Pigmentation
           14.6.2.3 Solar Lentigines
           14.6.2.4 Others
14.7 Middle East & Africa Market Value Share Analysis, by End-user
14.8 Middle East & Africa Market Forecast, by End-user
    14.8.1 Hospitals
    14.8.2 Aesthetic Clinics & Dermatology Centers
    14.8.3 Others
14.9 Market Analysis, by Country
14.10 Market Value Share Analysis, by Country
14.11 Market Size (US$ Mn) Forecast, by Country, 2018–2026
    14.11.1 GCC Countries
    14.11.2 South Africa
    14.11.3 Rest of Middle East & Africa
14.12 Market Attractiveness Analysis
    14.12.1 By Treatment
    14.12.2 By Disease Indication
    14.12.3 By Disease Hypopigmentation
    14.12.4 By Disease Hyperpigmentation
    14.12.5 By End-user
    14.12.6 By Country

Section 15 Competition Landscape
15.1 Competition Matrix
15.2 Pigmentation Disorders Treatment Market Share Analysis, by Company (2017)
15.3 Company Profiles
    15.3.1 Bayer AG
           15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
           15.3.1.2 Product Portfolio
           15.3.1.3 SWOT Analysis
           15.3.1.4 Strategic Overview
           15.3.1.5 Financial Overview
    15.3.2 ALLERGAN
           15.3.2.1 Company Overview (HQ, Business Segments, Employee Strength)
           15.3.2.2 Product Portfolio
           15.3.2.3 SWOT Analysis
           15.3.2.4 Strategic Overview
           15.3.2.5 Financial Overview
    15.3.3 Galderma S.A. (Nestle Skin Health S.A)
           15.3.3.1 Company Overview (HQ, Business Segments, Employee Strength)
           15.3.3.2 Product Portfolio
           15.3.3.3 SWOT Analysis
           15.3.3.4 Strategic Overview
    15.3.4 SkinCeuticals
           15.3.4.1 Company Overview (HQ, Business Segments, Employee Strength)
           15.3.4.2 Product Portfolio
           15.3.4.3 SWOT Analysis
           15.3.4.4 Strategic Overview
    15.3.5 Pierre Fabre
           15.3.5.1 Company Overview (HQ, Business Segments, Employee Strength)
           15.3.5.2 Product Portfolio
           15.3.5.3 SWOT Analysis
           15.3.5.4 Strategic Overview
           15.3.5.5 Financial Overview
    15.3.6 EpiPharm AG
           15.3.6.1 Company Overview (HQ, Business Segments, Employee Strength)
           15.3.6.2 Product Portfolio
           15.3.6.3 SWOT Analysis
           15.3.6.4 Strategic Overview
    15.3.7 RXi Pharmaceuticals Corporation
           15.3.7.1 Company Overview (HQ, Business Segments, Employee Strength)
           15.3.7.2 Product Portfolio
           15.3.7.3 SWOT Analysis
           15.3.7.4 Strategic Overview
           15.3.7.5 Financial Overview
    15.3.8 Obagi Cosmeceuticals LLC (Obagi medical)
           15.3.8.1 Company Overview (HQ, Business Segments, Employee Strength)
           15.3.8.2 Product Portfolio
           15.3.8.3 SWOT Analysis
           15.3.8.4 Strategic Overview
    15.3.9 Vivier Pharma
           15.3.9.1 Company Overview (HQ, Business Segments, Employee Strength)
           15.3.9.2 Product Portfolio
           15.3.9.3 SWOT Analysis
           15.3.9.4 Strategic Overview

List of Tables

Table 01: Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
Table 02: Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 03: Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hypopigmentation, 2016–2026
Table 04: Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hyperpigmentation, 2016–2026
Table 05: Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 06: Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 07: North America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 08: North America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 09: North America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hypopigmentation, 2016–2026
Table 10: North America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hyperpigmentation, 2016–2026
Table 11: North America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 12: Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 13: Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
Table 14: Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 15: Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hypopigmentation, 2016–2026
Table 16: Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hyperpigmentation, 2016–2026
Table 17: Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 18: Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 19: Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 20: Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 21: Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by hypopigmentation, 2016–2026
Table 22: Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hyperpigmentation, 2016–2026
Table 23: Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 24: Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 25: Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
Table 26: Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 27: Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hypopigmentation, 2016–2026
Table 28: Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hyperpigmentation, 2016–2026
Table 29: Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 30: Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 31: Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
Table 32: Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 33: Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hypopigmentation, 2016–2026
Table 34: Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Hyperpigmentation, 2016–2026
Table 35: Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026

List of Figures

Figure 01: Global Pigmentation Disorders Treatment Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
Figure 02: Global Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 03: Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017
Figure 04: Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017
Figure 05: Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017
Figure 06: Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017
Figure 07: Pigmentation Disorders Treatment Market Value Share, by End-user, 2017
Figure 08: Pigmentation Disorders Treatment Market Value Share, by Region, 2017
Figure 09: Global Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
Figure 10: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Topical Drugs, 2016–2026
Figure 11: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Laser Therapy, 2016–2026
Figure 12: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemical Peels, 2016–2026
Figure 13: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Microdermabrasion, 2016–2026
Figure 14: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Phototherapy, 2016–2026
Figure 15: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 16: Global Pigmentation Disorders Treatment Market Attractiveness Analysis, by Treatment, 2018–2026
Figure 17: Global Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
Figure 18: Global Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017 and 2026
Figure 19: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitiligo, 2016–2026
Figure 20: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Albinism, 2016–2026
Figure 21: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 22: Global Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017 and 2026
Figure 23: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Melasma, 2016–2026
Figure 24: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Post-inflammatory Hyperpigmentation, 2016–2026
Figure 25: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Solar Lentigines, 2016–2026
Figure 26: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 27: Global Pigmentation Disorders Treatment Market Attractiveness Analysis, by Disease Indication, 2018–2026
Figure 28 Global Pigmentation Disorders Treatment Market Attractiveness Analysis, by Hypopigmentation, 2018–2026
Figure 29: Global Pigmentation Disorders Treatment Market Attractiveness Analysis, by Hyperpigmentation, 2018–2026
Figure 30: Global Pigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
Figure 31: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2016–2026
Figure 32: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aesthetic Clinics & Dermatology Centers, 2016–2026
Figure 33: Global Pigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 34: Global Pigmentation Disorders Treatment Market Attractiveness Analysis, by End-user, 2018–2026
Figure 35: Global Pigmentation Disorders Treatment Market Value Share, by Region, 2017 and 2026
Figure 36: Global Pigmentation Disorders Treatment Market Attractiveness Analysis, by Region, 2018–2026
Figure 37: North America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 38: North America Pigmentation Disorders Treatment Market Value Share, by Country, 2017 and 2026
Figure 39: North America Pigmentation Disorders Treatment Market Attractiveness, by Country, 2018–2026
Figure 40: North America Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
Figure 41: North America Pigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
Figure 42: North America Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
Figure 43: North America Pigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
Figure 44: North America Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017 and 2026
Figure 45: North America Pigmentation Disorders Treatment Market Attractiveness, by Hypopigmentation, 2018–2026
Figure 46: North America Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017 and 2026
Figure 47: North America Pigmentation Disorders Treatment Market Attractiveness, by Hyperpigmentation, 2018–2026
Figure 48: North America Pigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
Figure 49: North America Pigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
Figure 50: Europe Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 51: Europe Pigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 52: Europe Pigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 53: Europe Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
Figure 54: Europe Pigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
Figure 55: Europe Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
Figure 56: Europe Pigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
Figure 57: Europe Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017 and 2026
Figure 58: Europe Pigmentation Disorders Treatment Market Attractiveness, by Hypopigmentation, 2018–2026
Figure 59: Europe Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017 and 2026
Figure 60: Europe Pigmentation Disorders Treatment Market Attractiveness, by Hyperpigmentation, 2018–2026
Figure 61: Europe Pigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
Figure 62: Europe Pigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
Figure 63: Asia Pacific Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 64: Asia Pacific Pigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 65: Asia Pacific Pigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 66: Asia Pacific Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
Figure 67: Asia Pacific Pigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
Figure 68: Asia Pacific Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
Figure 69: Asia Pacific Pigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
Figure 70: Asia Pacific Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017 and 2026
Figure 71: Asia Pacific Pigmentation Disorders Treatment Market Attractiveness, by Hypopigmentation, 2018–2026
Figure 72: Asia Pacific Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017 and 2026
Figure 73: Asia Pacific Pigmentation Disorders Treatment Market Attractiveness, by Hyperpigmentation, 2018–2026
Figure 74: Asia Pacific Pigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
Figure 75: Asia Pacific Pigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
Figure 76: Latin America Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 77: Latin America Pigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 78: Latin America Pigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 79: Latin America Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
Figure 80: Latin America Pigmentation Disorders Treatment Market Attractiveness, by Treatment Type, 2018–2026
Figure 81: Latin America Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
Figure 82: Latin America Pigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
Figure 83: Latin America Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017 and 2026
Figure 84: Latin America Pigmentation Disorders Treatment Market Attractiveness, by Hypopigmentation, 2018–2026
Figure 85: Latin America Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017 and 2026
Figure 86: Latin America Pigmentation Disorders Treatment Market Attractiveness, by Hyperpigmentation, 2018–2026
Figure 87: Latin America Pigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
Figure 88: Latin America Pigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
Figure 89: Middle East & Africa Pigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 90: Middle East & Africa Pigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 91: Middle East & Africa Pigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 92: Middle East & Africa Pigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
Figure 93: Middle East & Africa Pigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
Figure 94: Middle East & Africa Pigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
Figure 95: Middle East & Africa Pigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
Figure 96: Middle East & Africa Pigmentation Disorders Treatment Market Value Share, by Hypopigmentation, 2017 and 2026
Figure 97: Middle East & Africa Pigmentation Disorders Treatment Market Attractiveness, by Hypopigmentation, 2018–2026
Figure 98: Middle East & Africa Pigmentation Disorders Treatment Market Value Share, by Hyperpigmentation, 2017 and 2026
Figure 99: Middle East & Africa Pigmentation Disorders Treatment Market Attractiveness, by Hyperpigmentation, 2018–2026
Figure 100: Middle East & Africa Pigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
Figure 101: Middle East & Africa Pigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026

Transparency Market Research Plus

Get a free copy if the report you purchased is updated within 90 days

Copyright © Transparency Market Research, Inc. All Rights reserved